Bloomberg: The Opioid Epidemic’s First Corporate Casualty May Be a Drugmaker That Helped Fuel the Crisis
Insys’s aggressive sales tactics led to criminal charges. It’s trying to reinvent itself as a “cannabinoid pioneer.”
You need to be a member of The NIC Collaboration Hub to add comments!
Replies
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931647/